Modified Atkins diet is an effective treatment for children with Doose syndrome

Epilepsia

Volumn 58, Issue 4, 2017, Pages 657-662

  Wiemer Kruel, Adelheid ^a   Haberlandt, Edda ^b   Hartmann, Hans ^c   Wohlrab, Gabriele ^d   Bast, Thomas ^a  

^a Epilepsy Centre Kork   (Germany)

^b UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Ketogenic diet; Myoclonic astatic epilepsy; Pharmacoresistance

Indexed keywords

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; FEMALE; HUMAN; KETOGENIC DIET; MALE; MEDICAL RECORD REVIEW; MODIFIED ATKINS DIET; MYOCLONIC ASTATIC EPILEPSY; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; DIET THERAPY; LOW CARBOHYDRATE DIET; MYOCLONUS EPILEPSY; PRESCHOOL CHILD; PROCEDURES; TREATMENT OUTCOME;

CHILD; CHILD, PRESCHOOL; DIET, CARBOHYDRATE-RESTRICTED; EPILEPSIES, MYOCLONIC; FEMALE; HUMANS; MALE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 85013408878     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.13701     Document Type: Article

References (21)

1. McTague A, Cross JH. Treatment of epileptic encephalopathies. CNS Drugs 2013;27:175–184.
2. Oguni H, Fukuyama Y, Tanaka T, et al. Myoclonic-astatic epilepsy of early childhood – clinical and EEG analysis of myoclonic-astatic seizures, and discussions on the nosology of the syndrome. Brain Dev 2001;23:757–764.
3. Oguni H, Tanaka T, Hayashi K, et al. Treatment and long-term prognosis of myoclonic-astatic epilepsy of early childhood. Neuropediatrics 2002;33:122–132.
4. Stephani U. Myoclonic astatic epilepsy. In Nikanorova M, Genton P, Sabers A (Eds) Long-term evolution of epileptic encephalopathies. Esher (Surrey, UK): John Libbey Eurotext, 2009:39–50.
5. Stephani U. The natural history of myoclonic astatic epilepsy (Doose syndrome) and Lennox-Gastaut syndrome. Epilepsia 2006;47(Suppl. 2):53–55.
6. Kilaru S, Bergqvist C. Current treatment of myoclonic astatic epilepsy: clinical experience at the Children's Hospital of Philadelphia. Epilepsia 2007;48:1703–1707.
7. Von Stülpnagel C, Coppola G, Striano P, et al. First long-term experience with the orphan drug rufinamide in children with myoclonic-astatic epilepsy (Doose syndrome). Eur J Paediatr Neurol 2012;16:459–463.
8. Caraballo RH, Cersosimo RO, Sakr D, et al. Ketogenic diet in patients with myoclonic-astatic epilepsy. Epileptic Disord 2006;8:151–155.
9. Bergqvist AGC. Myoclonic astatic epilepsy and the use of the ketogenic diet. Epilepsy Res 2012;100:258–260.
10. Nangia S, Caraballo RH, Kang HC, et al. Is the ketogenic diet effective in specific epilepsy syndromes? Epilepsy Res 2012;100:252–257.
11. Simard-Tremblay E, Berry P, Owens A, et al. High-fat diets and seizure control in myoclonic-astatic epilepsy: a single center's experience. Seizure 2014;25:184–186.
12. Kossoff EH, Cervenka MC, Henry BJ, et al. A decade of the modified Atkins diet (2003–2013): results, insights, and future directions. Epilepsy Behav 2013;29:437–442.
13. Kang HC, Lee HS, You SJ, et al. Use of a modified Atkins diet in intractable childhood epilepsy. Epilepsia 2007;48:182–186.
14. Sharma S, Sankhyan N, Gulati S, et al. Use of the modified Atkins diet for treatment of refractory childhood epilepsy: a randomized controlled trial. Epilepsia 2013;54:481–486.
15. Kim JA, Yoon JR, Lee EJ, et al. Efficacy of the classic ketogenic and the modified Atkins diets in refractory childhood epilepsy. Epilepsia 2016;57:51–58.
16. Weber S, Mølgaard C, Taudorf K, et al. Modified Atkins diet to children and adolescents with medical intractable epilepsy. Seizure 2009;18:237–240.
17. Kossoff EH, Bosarge JL, Miranda MJ, et al. Will seizure control improve by switching from the modified Atkins diet to the traditional ketogenic diet? Epilepsia 2010;51:2496–2499.
18. Kumada T, Miyajima T, Oda N, et al. Efficacy and tolerability of modified Atkins diet in Japanese children with medication-resistant epilepsy. Brain Dev 2012;34:32–38.
19. Mullen SA, Marini C, Suls A, et al. Glucose transporter 1 deficiency as a treatable cause of myoclonic astatic epilepsy. Arch Neurol 2011;68:1152–1155.
20. Tang S, Pal DK. Dissecting the genetic basis of myoclonic-astatic epilepsy. Epilepsia 2012;53:1303–1313.
21. van der Louw EJ, Desadien R, Vehmeijer FO, et al. Concomitant lamotrigine use is associated with decreased efficacy of the ketogenic diet in childhood refractory epilepsy. Seizure 2015;32:75–77.